Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution

Michael R. Drapp, CEO of the newly-formed nanoEdge Technologies, LLC
Michael R. Drapp, CEO of the newly-formed nanoEdge Technologies, LLC

Abstract:
Michael R. Drapp, a 34-year veteran of the high-technology industry, has formed nanoEdge™ Technologies, a business development and intellectual property management company focused on the emerging nanotechnology space. The company also plans to invest in promising technologies and act as a nanotechnology incubator.

Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution

Monterey, CA | Posted on December 1st, 2009

Michael R. Drapp, a 34-year veteran of the high-technology industry, has formed nanoEdge™ Technologies, a business development and intellectual property management company focused on the emerging nanotechnology space. The company also plans to invest in promising technologies and act as a nanotechnology incubator.

"Nanotechnology is the next great frontier: for technology, for industry, and for humanity as a whole," says Drapp. "This isn't hyperbole. Every previous technological shift has been limited to mankind's external environment. Nanotechnology will also invade our internal space. Our medical treatments, our food, our entertainment…even our very definition of "self" will be impacted. This next shift will redefine the current demarcation between technology and humanity.

"Consider the title of the recent National Science Foundation report: 'Ethics of Human Enhancement'. They are talking about the use of technology to reengineer humanity - what some would call eugenics. Does this raise ethical, legal and environmental issues? Absolutely.

"But this emerging 'nanosphere' also presents incredible opportunity. I formed nanoEdge™ Technologies because I've seen too much valuable IP die on the vine or get highjacked because the brilliant people who developed the science weren't focused on or perhaps skilled at maximizing the commercial potential of their ideas.

"It's not enough to give somebody in your company a business development title to promote the mousetrap you think you have in your hand. You have to be able to see the emerging opportunities and identify innovative ways to combine that mousetrap with other technologies to create entirely new products and markets. This requires a particular skillset and experience base that can conceptualize and execute across multiple disciplines and industries and connect dots that others aren't seeing yet.

"For example, a Middle Eastern company came to us looking for funding for their nano-camera and nano-sensor technologies. They didn't realize they had already been eclipsed in the applications they were targeting by a European technology. We were able to give them some innovative ideas for adding value to their product design and creating new applications in other industries. This will help them better focus their final stage R&D and reposition their go-to-market strategy for a successful launch.

"This is where nanoEdge™ excells at adding value. We have an exceptional track record of creating multiplied returns for clients from opportunities that they didn't know they had.

"This expertise is even more critical for nanotech companies because more often than not, the true value of their IP is not in a single product but rather in the application of their IP to other products, services and technologies - what I term 'nanosynergistics'. You can't leverage this kind of integrated value via a traditional in-house sales and marketing model. You need a bigger network and higher levels of access. And you have to be able to envision and execute across multiple disciplines and industries.

"Our goal at nanoEdge™ is to help our clients productize and commercialize their intellectual properties to maximum advantage. Licensing, technology transfer, reengineering and design, new product development, mergers or acquisitions, venture capital, joint ventures, strategic partnerships - we'll leverage our networks and whichever channels and strategies will produce the best business and financial outcomes for each client.

"I started my first technology company when I was 20 and I've ridden a lot of market waves up and down over the years. But when I look out at the emerging nanospace and the technologies that are now in the lab or getting ready to launch, I can't see an end to this new wave - to the potential applications and their impacts. I can't think of an industry or area of life that won't be affected.

"And I can't think of anywhere else I'd rather invest than right here - on the 'nanoEdge' of the next technology revolution."

####

About nanoEdge™ Technologies
nanoEdge™ Technologies is a business development and intellectual property management company focused on emerging nanotechnologies and related applications. The company’s interdisciplinary approach combines hands-on expertise in operations, engineering and design, sales and marketing, and cash flow management with proven strategies for successfully identifying, productizing and commercializing new technologies in diverse market environments. For additional information on the company’s services, contact Linda Cavalli at or visit www.nanoedgetech.com. You can also follow Mr. Drapp’s musings on the emerging “nanosphere” on his new blog, (www.thenanoedge.com) and on Twitter (thenanoedge).

About Michael R. Drapp

Mr. Drapp has a track record of forecasting and leveraging emerging market and technology trends. His visionary 'outside-of-the-box' opportunity analysis and business execution have resulted in triple-digit revenue growth for the companies he has founded or worked for. In addition to executive-level experience with companies that include Fujitsu, Hitachi, Wang, Xerox and Hewlett-Packard, Mr. Drapp has served as CEO and founder of seven companies that have produced over a billion dollars in aggregate global revenue.

For more information, please click here

Copyright © PRWeb

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project